Multinational biopharmaceutical firm Gilead Sciences has launched a 90,000 sq ft requirement in Cambridge as it looks to double the amount of space it occupies in the city. Knight Frank has beenThank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
